147 related articles for article (PubMed ID: 27303917)
1. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer.
Kong F; Gao F; Chen J; Zheng R; Liu H; Li X; Yang P; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(34):55765-55770. PubMed ID: 27303917
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
6. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.
Kong F; Qi Y; Liu H; Gao F; Yang P; Li Y; Jia Y
Clin Transl Oncol; 2015 Nov; 17(11):917-24. PubMed ID: 26088414
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Serum C-Reactive Protein Level Predicts Long-term Outcomes in Stage I Gastric Cancer.
Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
J Surg Res; 2019 Oct; 242():323-331. PubMed ID: 31129241
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.
Yu Q; Yu XF; Zhang SD; Wang HH; Wang HY; Teng LS
Asian Pac J Cancer Prev; 2013; 14(10):5735-40. PubMed ID: 24289571
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Features of Remnant Gastric Cancer (RGC): Detection of RGC after Five Years of Follow-Up Was Associated with a Poor Prognosis.
Kameda C; Kawabata R; Koga C; Matsumura T; Murakami M; Noura S; Shimizu J; Hasegawa J
Am Surg; 2019 Apr; 85(4):384-389. PubMed ID: 31043199
[TBL] [Abstract][Full Text] [Related]
11. High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.
Shao N; Cai Q
Tumour Biol; 2015 Nov; 36(11):8465-70. PubMed ID: 26026588
[TBL] [Abstract][Full Text] [Related]
12. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Platelet-Based Inflammatory Indicators in Patients with Gastric Cancer.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Aug; 42(8):2542-2550. PubMed ID: 29464343
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment.
Alan O; Telli TA; Basoğlu T; Arikan R; Demircan NC; Ercelep O; Bozkurt S; Atasoy BM; Dane F; Yumuk PF
Clin Neurol Neurosurg; 2020 Sep; 196():105976. PubMed ID: 32531614
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study.
Kurokawa Y; Yamashita K; Kawabata R; Fujita J; Imamura H; Takeno A; Takahashi T; Yamasaki M; Eguchi H; Doki Y
Gastric Cancer; 2020 Sep; 23(5):937-943. PubMed ID: 32314097
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.
Sevcenco S; Mathieu R; Baltzer P; Klatte T; Fajkovic H; Seitz C; Karakiewicz PI; Rouprêt M; Rink M; Kluth L; Trinh QD; Loidl W; Briganti A; Scherr DS; Shariat SF
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):163-7. PubMed ID: 26810014
[TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
